Clinical Trial Update: Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing disease-modifying antirheumatic drugs in patients with rheumatoid arthritis who failed methotrexate monotherapy; study terminated with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-06-10